Fibrous dysplasia animal models: A systematic review

被引:7
作者
Hopkins, Chelsea [1 ]
de Castro, Luis Fernandez [2 ]
Corsi, Alessandro [3 ]
Boyce, Alison [4 ]
Collins, Michael T. [2 ]
Riminucci, Mara [3 ]
Heegaard, Anne-Marie [1 ]
机构
[1] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark
[2] Natl Inst Dent & Craniofacial Res, Skeletal Disorders & Mineral Homeostasis Sect, NIH, Bethesda, MD USA
[3] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
[4] Natl Inst Dent & Craniofacial Res, Metab Bone Disorders Unit, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
Fibrous dysplasia; In vivo; Animal; PROTEIN-KINASE-A; SKELETAL STEM-CELLS; MCCUNE-ALBRIGHT SYNDROME; QUALITY-OF-LIFE; OSTEOBLAST EXPRESSION; COUPLED RECEPTOR; GROWTH-HORMONE; STROMAL CELLS; BONE; ACTIVATION;
D O I
10.1016/j.bone.2021.116270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fibrous dysplasia (FD) is a rare genetic bone disorder resulting in an overproduction of cAMP leading to a structurally unsound tissue, caused by a genetic mutation in the guanine nucleotide-binding protein gene (GNAS). In order to better understand this disease, several animal models have been developed with different strategies and features. Objective: Conduct a systematic review to analyze and compare animal models with the causative mutation and features of FD. Methods: A PRISMA search was conducted in Scopus, PubMed, and Web of Science. Studies reporting an in vivo model of FD that expressed the causative mutation were included for analysis. Models without the causative mutation, but developed an FD phenotype and models of FD cell implantation were included for subanalysis. Results: Seven unique models were identified. The models were assessed and compared for their face validity, construct validity, mosaicism, and induction methods. This was based on the features of clinical FD that were reported within the categories of: macroscopic features, imaging, histology and histomorphometry, histochemical and cellular markers, and blood/urine markers. Limitations: None of the models reported all features of FD and some features were only reported in one model. This made comparing models a challenge, but indicates areas where further research is necessary. Conclusion: The benefits and disadvantages of every model were assessed from a practical and scientific standpoint. While all published reports lacked complete data, the models have nonetheless informed our understanding of FD and provided meaningful information to guide researchers in bench and clinical research.
引用
收藏
页数:13
相关论文
共 83 条
[1]   Disrupted Bone Remodeling Leads to Cochlear Overgrowth and Hearing Loss in a Mouse Model of Fibrous Dysplasia [J].
Akil, Omar ;
Hall-Glenn, Faith ;
Chang, Jolie ;
Li, Alfred ;
Chang, Wenhan ;
Lustig, Lawrence R. ;
Alliston, Tamara ;
Hsiao, Edward C. .
PLOS ONE, 2014, 9 (05)
[2]   Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome [J].
Akintoye, SO ;
Chebli, C ;
Booher, S ;
Feuillan, P ;
Kushner, H ;
Leroith, D ;
Cherman, N ;
Bianco, P ;
Wientroub, S ;
Robey, PG ;
Collins, MT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) :5104-5112
[3]   Mechanism of FGF23 processing in fibrous dysplasia [J].
Bhattacharyya, Nisan ;
Wiench, Malgorzata ;
Dumitrescu, Claudia ;
Connolly, Brian M. ;
Bugge, Thomas H. ;
Patel, Himatkumar V. ;
Gafni, Rachel I. ;
Cherman, Natasha ;
Cho, Monique ;
Hager, Gordon L. ;
Collins, Michael T. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (05) :1132-1141
[4]   Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsα-mutated skeletal progenitor cells [J].
Bianco, P ;
Kuznetsov, SA ;
Riminucci, M ;
Fisher, LW ;
Spiegel, AM ;
Robey, PG .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1737-1744
[5]   Denosumab treatment for fibrous dysplasia [J].
Boyce, Alison M. ;
Chong, William H. ;
Yao, Jack ;
Gafni, Rachel I. ;
Kelly, Marilyn H. ;
Chamberlain, Christine E. ;
Bassim, Carol ;
Cherman, Natasha ;
Ellsworth, Michelle ;
Kasa-Vubu, Josephine Z. ;
Farley, Frances A. ;
Molinolo, Alfredo A. ;
Bhattacharyya, Nisan ;
Collins, Michael T. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (07) :1462-1470
[6]   Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone [J].
Calvi, LM ;
Sims, NA ;
Hunzelman, JL ;
Knight, MC ;
Giovannetti, A ;
Saxton, JM ;
Kronenberg, HM ;
Baron, R ;
Schipani, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :277-286
[7]   INCREASED EXPRESSION OF THE C-FOS PROTOONCOGENE IN BONE FROM PATIENTS WITH FIBROUS DYSPLASIA [J].
CANDELIERE, GA ;
GLORIEUX, FH ;
PRUDHOMME, J ;
STARNAUD, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) :1546-1551
[8]   Osteochondromyxoma of bone - A congenital tumor associated with lentigines and other unusual disorders [J].
Carney, JA ;
Boccon-Gibod, L ;
Jarka, DE ;
Tanaka, Y ;
Swee, RG ;
Unni, KK ;
Stratakis, CA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (02) :164-176
[9]   Fibrous dysplasia of bone [J].
Chapurlat, RD ;
Meunier, PJ .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2000, 14 (02) :385-398
[10]   Fibrous dysplasia of bone and McCune-Albright syndrome [J].
Chapurlat, Roland D. ;
Orcel, Philippe .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2008, 22 (01) :55-69